Prognostic value of BCL-2, cyclin E and cyclin dependent kinase inhibitor (P27) genes expression in non-Hodgkin lymphoma - Egyptian Knowledge Bank - troweb

39416

Prognostic value of BCL-2, cyclin E and cyclin dependent kinase inhibitor (P27) genes expression in non-Hodgkin lymphoma

Thesis

Last updated: 06 Feb 2023

Overview Similar Items

Thesis

Cyclin D1 in acute lymphoblastic leukemia: A prognostic marker

Thesis

The role of cyclin dependent kinase inhibitor p27 in chronic lymphocytic leukemia

Thesis

The clinical relevance of BCL2 & BCL6 immunohistochemical expression in B-cell non hodgkin lymphoma: An Egyptian study

Thesis

Level of expression of CD20 in chronic lymphocytic leukemia and non-Hodgkin’s lymphoma

Thesis

A prospective study for the assessment of gene dysregulation in B-cell oncogenesis using complementary DNA microarray

Thesis

Prognostic significance of CD20 expression in pediatricclassical Hodgkin lymphoma

Thesis

Recent advances in prognostic markers of haematologic malignancies

Thesis

Implication of 6q aberration in non hodgkin lymphoma

Thesis

Expression of fibromodulin gene as a tumor associated antigen in B-cell chronic lymphocytic leukemia

Thesis

Study of p27kip1 as an emergingprognostic marker for breast duct carcinomas